Key result
Familial idiopathic dilated cardiomyopathy (confirmed in 9% of families) was associated with worse 1-year and 5-year survival in NYHA class III and IV patients compared to non-familial cases.
Why the study?
Does familial idiopathic dilated cardiomyopathy have different clinical characteristics and prognosis compared to non-familial cases?
Observational (n=117)
Does familial idiopathic dilated cardiomyopathy have different clinical characteristics and prognosis compared to non-familial cases?
Familial idiopathic dilated cardiomyopathy is associated with a worse prognosis and higher risk of sudden death once symptoms become severe (NYHA III-IV) compared to non-familial cases.
May inform family screening in advanced DCM; leaves open whether genotype-specific therapies improve outcomes.
To investigate the prevalence, clinical characteristics, and prognosis of familial cases of idiopathic dilated cardiomyopathy (IDC), family screenings were carried out in 117 IDC patients and their relatives. Familial occurrence was suspected in 29 families (25%). Ten families (9%) with 24 patients were confirmed to be familial, but the other 19 families (16%) remained suspected. The age at the time of diagnosis was lower and the cardiac symptoms tended to be milder in the familial group than in the non-familial group, but there were no differences in other clinical parameters. There was also no difference in the survival rate. However, when only NYHA class III and IV patients were selected, the 1-year and 5-year survival rates were lower in the familial group than in the non-familial group. Congestive heart failure was the most common cause of death in the non-familial group, while sudden death was the most common cause of death in the familial group. Among familial IDC patients who were deceased, the left ventricular end-diastolic pressure was higher and the cardiac index was lower at the time of diagnosis than those in patients who were still alive. We conclude that, since the prognosis of familial IDC patients is poor once their cardiac symptoms become severe, early diagnosis and treatment are extremely important.
No takes yet. Share an insight, caveat, or question.
Honda et al. (1995) conducted an observational in Idiopathic dilated cardiomyopathy (n=117). Familial idiopathic dilated cardiomyopathy vs. Non-familial idiopathic dilated cardiomyopathy was evaluated on Survival rate. Familial idiopathic dilated cardiomyopathy (confirmed in 9% of families) was associated with worse 1-year and 5-year survival in NYHA class III and IV patients compared to non-familial cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: